Fig. 1
From: UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K/AKT activation
The leukemia cell lines show a high level of UBE2C expression. (A) GEPIA analysis indicates the UBE2C expression in the TCGA database. (B) The qRT-PCR analysis presents the UBE2C expression levels in the peripheral blood of 50 AML and 50 normal subjects. (C) KM-plotter displays the plotted survival curves of AML patients with high- and low-UBE2C expression groups. (D) The qRT-PCR analysis presents the UBE2C expression levels in AML cells and the human bone marrow stromal cell line, HS-5. (E) The WB analysis displays the expression levels of UBE2C protein in AML cell lines and the human bone marrow stromal cell line, HS-5. ** indicates P < 0.01 compared with Normal and HS-5 groups; *** represents P < 0.001 compared with HS-5 group